Herbas VPB

Print
EN | LT
LT - Monokloniniai antikūnai prieš programuojamą mirtį 1 (PD-1)
EN - MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1)

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C12N 15/13 (2006.01)
C12N 15/63 (2006.01)
C12N 5/10 (2006.01)
C12N 5/20 (2006.01)
European patent
(11) Number of the document 3515938
(13) Kind of document T
(96) European patent application number 16916449.8
Date of filing the European patent application 2016-09-21
(97) Date of publication of the European application 2019-07-31
(45) Date of publication and mention of the grant of the patent 2025-01-08
(46) Date of publication of the claims translation 2025-05-12
PCT application
(86) Number PCT/CN2016/099576
Date 2016-09-21
PCT application publication
(87) Number WO 2018/053709
Date 2018-03-29
Inventors
(72)
ZHENG, Yong , CN
LI, Jing , US
GOLOLOBOV, Gennady , US
ZHANG, Xinhua , CN
YANG, Baotian , CN
TANG, Zhewei , CN
LI, Dong , CN
XU, Jianqing , CN
WANG, Zhuozhi , US
Grantee
(73) CSTONE PHARMACEUTICALS , P.O. Box 31119, Grand Pavilion Hibiscus Way 802 West Bay Road, KY1-1205 Grand Cayman, KY
CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. , 218 Xinghu St, Building A1 E168 Suzhou Industrial Park, Jiangsu 215123, CN
CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD. , Room 211-20, Building 1 38 Debao Road Pilot Free Trade Zone, Shanghai 200000, CN
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Monokloniniai antikūnai prieš programuojamą mirtį 1 (PD-1)
  MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1)
Last renewal fee
Payment date Validity (years) Amount
2025-09-03 10 231.00 EUR
Next renewal fee
2026-09-21